Erratum: Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway

MLA

D Ding, et al. “Erratum: Reticulocalbin-2 Enhances Hepatocellular Carcinoma Proliferation via Modulating the EGFR-ERK Pathway.” Oncogene, vol. 36, Nov. 2017, pp. 6747–48. EBSCOhost, https://doi.org/10.1038/onc.2017.366.

APA

D Ding, H Huang, W Jiang, W Yu, H Zhu, J Liu, H Saiyin, J Wu, S Jiang, & L Yu. (2017). Erratum: Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway. Oncogene, 36, 6747–6748. https://doi.org/10.1038/onc.2017.366

Chicago

D Ding, H Huang, W Jiang, W Yu, H Zhu, J Liu, H Saiyin, J Wu, S Jiang, and L Yu. 2017. “Erratum: Reticulocalbin-2 Enhances Hepatocellular Carcinoma Proliferation via Modulating the EGFR-ERK Pathway.” Oncogene 36 (November): 6747–48. doi:10.1038/onc.2017.366.